The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 50% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 104%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (4 analysts) rates it buy, with a mean price target of $274.
Plexus Corp. PLXS
Clears both ethical standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Plexus Corp.
read at $250.63
Plexus Corp. holds its Distribution at $250.63.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · passes the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 3 days |
| Price | $250.63 |
| Valuation | 36.64 trailing · 26.46 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.88 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | 18.70% |
| Profit margin | 4.35% |
| Debt to equity | 17.97 |
| Analyst consensus | Buy · 4 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company clears both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. Here is how it did on each:
Used by most halal investing apps ✓ PASSES
The one Titan applies ✓ PASSES
What these two standards are, and how they differ →
- Business activity Its core business isn't built on prohibited lines — no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Electronics assembler with slim safety margin
Picture the circuit boards inside medical gear or industrial machines. Someone has to design, source and build them at scale. Plexus does exactly that across the US, Asia and Europe, and it is growing revenue 19 percent a year while clearing a thin 4 percent profit margin.
We pass because the numbers do not add up to an edge. At 26.5 times forward earnings the shares already price in decent growth, yet the margin of safety is just 8 percent and return on equity sits at only 13 percent with no clear moat. Analyst targets around 292 dollars offer little extra room once normal volatility hits.
Low margins leave little cushion if component costs rise or customers push back on pricing. Unknown competitive durability adds further uncertainty even though the ethical screen is clear. Analysis, not advice.
| Forward P/E | 26.5x priced for continued growth |
| Trailing P/E | 36.6x expensive — the price assumes strong growth ahead |
| Revenue growth | 18.7% steady growth |
| Profit margin | 4.4% barely profitable |
| Return on equity | 13.2% a solid return on shareholder capital |
| Debt to equity | 0.18 minimal debt — a conservative balance sheet |
| Current ratio | 1.54 healthy short-term liquidity |
| Beta | 0.88 steadier than the market |
| Market cap | $6.7B |
| Employees | 20,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in PLXS's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
PLXS trades on Nasdaq. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $271.78 | +1.7% | · | $1,017 | +1.7% |
| 2 months | $227.58 | +21.5% | · | $1,215 | +21.5% |
| 3 months | $189.76 | +45.7% | · | $1,457 | +45.7% |
| 6 months | $166.89 | +65.6% | · | $1,656 | +65.6% |
| 1 year | $135.38 | +104.2% | · | $2,042 | +104.2% |
| 2 years | $102.42 | +169.9% | · | $2,699 | +169.9% |
| 3 years | $95.04 | +190.9% | · | $2,909 | +190.9% |
| 5 years | $91.85 | +201.0% | · | $3,010 | +201.0% |
Historical returns from market close data. Past performance does not guarantee future results.